Coming Events
Key Events at ACC 2009
2009 Medical Convention Information
American College of Cardiology (ACC)
Mar. 29- Mar. 31
Venue TBD
Orlando, FL
Visit www.acc.org
for more information.
Annual Interventional Cardiology Fellows Course (Fellows)
Mar. 28-Mar. 31
Venue TBD
Orlando, FL
Visit www.crf.org
for more information.
American Association of Critical-Care Nurses (AACN)
National Teaching Institute & Critical-Care Expo
May 16-21
Ernest N. Memorial Convention Center
New Orleans, LA
Visit www.aacn.org
for more information.
Transcatheter Cardiovascular Therapeutics (TCT)
TCT 2009
Sept 22-26
Moscone Convention Center
San Francisco, CA
Visit www.tctconference.com/
for more information.
American College of Emergency Physcians (ACEP)
Oct. 5-8
Hymes Convention Center
Boston, MA
Visit www.acep.org/
for more information.
Emergency Nurses Association (ENA)
Oct. 8-10
Baltimore Convention Center
Baltimore, MD
Visit www.ena.org/
for more information.
American College of Clinical Pharmacy (ACCP)
Annual Meeting
Oct. 18-21
Anaheim Convention Center
Anaheim, CA
Visit www.accp.com
for more information.
American Society of Health-System Pharmacists (ASHP)
Dec. 6-10
Venue TBD
Las Vegas, Nevada
Visit www.ashp.org
for more information.
The Society for Cardiovascular Angiography and Interventions (SCAI) -
Fellows Program
Date TBD
Mirage Hotel and Convention Center
Las Vegas, NV
Visit www.scai.org
for more information.
Safety Considerations
ANGIOMAX with provisional use of glycoprotein IIb/IIIa inhibitor is indicated for
use as an anticoagulant in patients undergoing percutaneous coronary intervention
(PCI), and in patients with or at risk for heparin-induced thrombocytopenia and
thrombosis syndrome (HIT/HITTS) undergoing PCI. ANGIOMAX is intended for use with
aspirin and has been studied only in patients receiving concomitant aspirin. ANGIOMAX
is contraindicated in patients with active major bleeding or hypersensitivity to
ANGIOMAX or its components. The most common (≥10%) adverse events for ANGIOMAX were back pain, pain, nausea, headache,
and hypotension. An unexplained fall in blood pressure or hematocrit, or any unexplained
symptom, should lead to serious consideration of a hemorrhagic event and cessation
of ANGIOMAX administration. Please see complete prescribing information.